At Lilly, the Synthetic Molecule Design and Development (SMDD) group develops analytical methods and conducts experiments to enable early clinical formulation development for a broad range of drug molecules. The team collaborates with formulation scientists, analytical chemists, and engineers to determine optimal drug forms and formulations.
The role emphasizes identifying technical risks, adhering to GLP/GMP standards, and authoring key regulatory documents to support clinical trials and
#J-18808-LjbffrBiopharm Modeling Scientist: Dissolution & Formulation in indianapolis at Unknown Company
This position is listed as full time and onsite.